Health risks related to illegal and on-line sale of drugs and food supplements: results of a survey on marketed products in Italy from 2011 to 2013

Health risks related to illegal and on-line sale of drugs and food supplements: results of a survey on marketed products in Italy from 2011 to 2013

Objectives. The increasing illegal and on-line market of medicines and food supplements is helping the widespread diffusion of harmful counterfeit and forbidden products among consumers of developed countries. The objectives of this survey were the description of the main frauds recognized by public officers and the detection of illegal or counterfeit drugs and food supplements.

Methods. Medicines and food supplements found by Police forces on the illegal market or resulting from seizures made by Italian Customs authorities were visually inspected and analysed to evaluate their quality and the presence of other undeclared substances.

Results. The visual inspection and the chemical analysis revealed unsuitable packaging (mostly lacking of adequate information for consumers), absence of the declared active substances and presence of undeclared active substances. Products containing doping agents, illegal substances and active ingredients requiring medical supervision were found.

Conclusion. The present work confirmed the health risk associated with assumption of medicines purchased on the Internet and from the illegal supply chain and evidenced a new threat to consumer safety related to the presence of pharmaceutical active ingredients in food supplements claiming to contain only “natural ingredients”.

Keywordscounterfeit medicines, food supplements, PDE5-i, slimming agents, doping agents, excipient

Download

Health risks related to illegal and on-line sale of drugs and food supplements: results of a survey on marketed products in Italy from 2011 to 2013
Maria Cristina Gaudiano, Livia Manna, Monica Bartolomei, Andrea Luca Rodomonte,
Paola Bertocchi, Eleonora Antoniella, Laura Romanini, Stefano Alimonti, Leandro Rufini
and Luisa Valvo
Dipartimento del Farmaco, Istituto Superiore di Sanità, Rome, Italy
Ann Ist Super Sanità 2016 | Vol. 52, No. 1: 128-132
DOI: 10.4415/ANN_16_01_21
104-1211-1-PB.pdf
Adobe Acrobat Document 103.2 KB

You might also like